Amneal Pharmaceuticals has launched a generic version of Vyvanse (lisdexamfetamine dimesylate) capsules for the treatment of attention deficit hyperactivity disorder (ADHD) in adults and children six years and older [1]. This launch follows the expiration of patents protecting the brand-name drug [2].
When Does Vyvanse Patent Protection End?
The primary patents for Vyvanse have expired, allowing for the introduction of generic versions. This development is significant for the availability and cost of ADHD treatment [2].
Who Makes the Generic Version of Vyvanse?
Amneal Pharmaceuticals is one of the companies that has released a generic lisdexamfetamine dimesylate product [1]. Other manufacturers may also be producing or preparing to release their own versions of the generic drug.
How Does Generic Vyvanse Compare to Brand-Name Vyvanse?
Generic medications, including the lisdexamfetamine dimesylate offered by Amneal, are designed to be bioequivalent to their brand-name counterparts. This means they contain the same active ingredient, dosage form, strength, and route of administration, and they are expected to have the same clinical effect and safety profile [3]. The U.S. Food and Drug Administration (FDA) requires generic drugs to meet the same standards of quality and purity as brand-name drugs [4].
What Are the Cost Implications of Generic Vyvanse?
The introduction of generic alternatives typically leads to a significant reduction in the cost of medication. Patients and insurance providers can expect lower prices for lisdexamfetamine dimesylate compared to brand-name Vyvanse [2, 3].
What Other Generics for Vyvanse Might Be Available?
As patent exclusivity lapses, multiple pharmaceutical companies often enter the market with generic versions of a popular drug. Patients and healthcare providers can anticipate the availability of lisdexamfetamine dimesylate from various generic manufacturers [2].
What is Lisdexamfetamine Dimesylate Used For?
Lisdexamfetamine dimesylate is prescribed to treat attention deficit hyperactivity disorder (ADHD) in individuals aged six years and older. It is also used for the treatment of moderate to severe binge eating disorder in adults [1].
What Are the Potential Side Effects of Lisdexamfetamine Dimesylate?
Common side effects of lisdexamfetamine dimesylate may include decreased appetite, dry mouth, trouble sleeping, weight loss, anxiety, irritability, increased heart rate, and increased blood pressure [1]. Serious side effects can include psychiatric problems, circulation problems, and the potential for abuse or dependence [1].
How Does Amneal's Generic Vyvanse Fit into the ADHD Market?
The availability of Amneal's generic lisdexamfetamine dimesylate increases competition in the ADHD medication market. This can lead to greater access and affordability for patients requiring treatment for ADHD [2, 3].
What Regulatory Approvals Are Needed for Generic Drugs?
Generic drug manufacturers must submit an Abbreviated New Drug Application (ANDA) to the FDA. This application demonstrates that the generic drug is bioequivalent to the brand-name drug and meets all the same manufacturing and quality standards [4].
Where Can I Find More Information on Drug Patents?
Information regarding drug patents, including those for Vyvanse and its generic counterparts, can be found on DrugPatentWatch.com [2].
Sources
1. Amneal Pharmaceuticals LLC. (n.d.). Lisdexamfetamine Dimesylate Capsules. Retrieved from https://www.amneal.com/products/
2. DrugPatentWatch.com. (n.d.). Vyvanse Patent Expiration. Retrieved from https://drugpatentwatch.com/
3. U.S. Food and Drug Administration. (n.d.). Generic Drugs: Questions and Answers. Retrieved from https://www.fda.gov/drugs/generic-drugs/generic-drugs-questions-and-answers
4. U.S. Food and Drug Administration. (n.d.). How an ANDA Works. Retrieved from https://www.fda.gov/drugs/abbreviated-new-drug-application-anda/how-anda-works